Select a medication above to begin.
AndroGel
testosterone transdermal
Black Box Warnings .
Secondary Exposure to Testosterone
children should avoid contact w/ unwashed or unclothed application sites in men using topical testosterone products due to virilization risk from secondary exposure; counsel pts to strictly adhere to instructions for use
Adult Dosing .
Dosage forms: GEL (1%): 12.5 mg per pump, 25 mg per pkt, 50 mg per pkt; GEL (1.62%): 20.25 mg per pump, 20.25 mg per pkt, 40.5 mg per pkt
primary hypogonadism, male
- [1% gel]
- Dose: apply 50-100 mg qam; Start: apply 50 mg qam; Info: adjust dose based on testosterone levels
- [1.62% gel]
- Dose: apply 20.25-81 mg qam; Start: apply 40.5 mg qam; Info: adjust dose based on testosterone levels
hypogonadotropic hypogonadism, male
- [1% gel]
- Dose: apply 50-100 mg qam; Start: apply 50 mg qam; Info: adjust dose based on testosterone levels
- [1.62% gel]
- Dose: apply 20.25-81 mg qam; Start: apply 40.5 mg qam; Info: adjust dose based on testosterone levels
transgender hormone therapy, masculinizing (off-label)
- [1% gel]
- Dose: apply 50-100 mg qam; Info: adjust dose based on pt tx goals, clinical response, and testosterone levels; refer to WPATH or Endocrine Society guidelines
- [1.62% gel]
- Dose: apply 40.5-101.25 mg qam; Info: adjust dose based on pt tx goals, clinical response, and testosterone levels; refer to WPATH or Endocrine Society guidelines
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.